The child DB_Table objects that are associated with RDBMS tables must all be instantiated first, and then added to (i.e., linked with) a parent DB_Table_Database object.〔【出典】PEAR ◆【License】Open Publication License ◆【編集】独立行政法人情報通信研究機構 〕
これらの試験は後述(第Ⅵ章)のごとく実施されるべきである。
These studies should be performed as described below (Section VI).〔【出典】ICHガイドライン 〕
すべての不純物について、後述の記載に従って安全性を確認する。
All impurities should be qualified as described later in this guideline.〔【出典】ICHガイドライン 〕
In selecting viruses to use for a clearance study, it is useful to distinguish between the need to evaluate processes for their ability to clear viruses that are known to be present and the desire to estimate the robustness of the process by characterising the clearance of non-specific "model" viruses (described later).〔【出典】ICHガイドライン 〕
For the default database table schema or to use a different storage container, please see below for more information.〔【出典】PEAR ◆【License】Open Publication License ◆【編集】独立行政法人情報通信研究機構 〕
問題を後述する
carry the discussion forward(本などで)
彼の立場については、後述することにしよう。
We will talk more about his situation later.〔【出典】『日本のスーパーヒーロー伝説』(ルー・ウェイ著)◆【出版社】株式会社ヤック企画 〕"YA04-152", "2555365"
The overall adverse event experience in the study should be described in a brief narrative, supported by the following more detailed tabulations and analyses.〔【出典】ICHガイドライン 〕
It will be shown later in this paper that doing away with slow working and "soldiering" in all its forms and so arranging the relations between employer and employs that each workman will work to his very best advantage and at his best speed, accompanied by the intimate cooperation with the management and the help (which the workman should receive) from the management, would result on the average in nearly doubling the output of each man and each machine.〔【出典】日英対訳文・対応付けデータ(独立行政法人情報通信研究機構)〕"_PRI3-", "2382951"
The threshold level of regulatory concern, discussed further below, is around 5 ms as evidenced by an upper bound of the 95% confidence interval around the mean effect on QTc of 10 ms.〔【出典】ICHガイドライン 〕
Similar approaches (see below) to minimising bias in open-label trials should be considered in trials where unique or specific treatment effects may lead to unblinding individual patients.〔【出典】ICHガイドライン 〕